45
Participants
Start Date
April 10, 2019
Primary Completion Date
July 28, 2020
Study Completion Date
July 28, 2020
Oxycodone
The primary endpoint will be pain scores, calculated by the Visual Analog Scale. This score will be collected daily during the hospital examination and by phone surveys for two weeks following discharge. Investigators hypothesize that the non-opioid pain regimen will provide equivalent relief as compared to the opioid regimen.
Placebo Oral Tablet
The primary endpoint will be pain scores, calculated by the Visual Analog Scale. This score will be collected daily during the hospital examination and by phone surveys for two weeks following discharge. Investigators hypothesize that the non-opioid pain regimen will provide equivalent relief as compared to the opioid regimen.
Mayo Clinic in Florida, Jacksonville
Lead Sponsor
Collaborators (2)
Ambit Biosciences Corporation
INDUSTRY
Kern Medical Center
OTHER
Mayo Clinic
OTHER